• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血流衰竭是黄酮乙酸抗肿瘤作用的主要决定因素。

Blood flow failure as a major determinant in the antitumor action of flavone acetic acid.

作者信息

Zwi L J, Baguley B C, Gavin J B, Wilson W R

机构信息

Department of Pathology, University of Auckland School of Medicine, New Zealand.

出版信息

J Natl Cancer Inst. 1989 Jul 5;81(13):1005-13. doi: 10.1093/jnci/81.13.1005.

DOI:10.1093/jnci/81.13.1005
PMID:2733044
Abstract

Some investigators have suggested that the marked activity of flavone acetic acid (FAA) against advanced solid tumors in mice results from an indirect effect. This study indicates that the critical effect of FAA is irreversible inhibition of tumor blood flow. Perfusion of sc Colon 38 tumors, assessed with H33342 as a fluorescent stain for functional blood vessels, was reduced to 50% of controls within 3 hours of an ip injection of 1.2 mmol of FAA/kg and was completely inhibited by 24 hours. A double-label fluorescence technique demonstrated a significant decrease in blood flow in both sc Colon 38 and im EMT-6/Ak tumors as early as 15 minutes after iv treatment with 1.2 mmol of FAA/kg, with progressively enlarging zones of perfusion failure. The rate of cell death in totally ischemic EMT-6 tumors was shown to be sufficiently rapid to represent a major component of the observed antitumor effect of FAA if the flavonoid acts via inhibition of blood flow. Further, avascular EMT-6/Ak multicellular spheroids growing in the mouse peritoneum are relatively resistant to killing by FAA administered iv or ip, despite extensive infiltration with host immune cells. These results indicate that inhibition of tumor blood flow by FAA is a necessary component of its antitumor activity against solid tumors.

摘要

一些研究人员认为,黄酮醋酸(FAA)对小鼠晚期实体瘤具有显著活性是由间接作用所致。本研究表明,FAA的关键作用是对肿瘤血流的不可逆抑制。以H33342作为功能性血管的荧光染料评估皮下接种的结肠38肿瘤的灌注情况,腹腔注射1.2 mmol/kg的FAA后3小时内,灌注减少至对照的50%,24小时时完全被抑制。一种双标记荧光技术表明,静脉注射1.2 mmol/kg的FAA后15分钟,皮下接种的结肠38肿瘤和原位接种的EMT-6/Ak肿瘤的血流均显著减少,灌注衰竭区域逐渐扩大。如果类黄酮通过抑制血流发挥作用,完全缺血的EMT-6肿瘤中的细胞死亡速度足以快到成为观察到的FAA抗肿瘤作用的主要组成部分。此外,尽管有大量宿主免疫细胞浸润,但在小鼠腹膜中生长的无血管EMT-6/Ak多细胞球体对静脉注射或腹腔注射的FAA杀伤相对耐药。这些结果表明,FAA对肿瘤血流的抑制是其对实体瘤抗肿瘤活性的必要组成部分。

相似文献

1
Blood flow failure as a major determinant in the antitumor action of flavone acetic acid.血流衰竭是黄酮乙酸抗肿瘤作用的主要决定因素。
J Natl Cancer Inst. 1989 Jul 5;81(13):1005-13. doi: 10.1093/jnci/81.13.1005.
2
Reduction of tumor blood flow by flavone acetic acid: a possible component of therapy.
J Natl Cancer Inst. 1989 Feb 1;81(3):216-20. doi: 10.1093/jnci/81.3.216.
3
The use of vascularised spheroids to investigate the action of flavone acetic acid on tumour blood vessels.利用血管化球体研究黄酮乙酸对肿瘤血管的作用。
Br J Cancer. 1990 Aug;62(2):231-7. doi: 10.1038/bjc.1990.266.
4
Effect of flavone acetic acid on Lewis lung carcinoma: evidence for an indirect effect.黄酮乙酸对Lewis肺癌的作用:间接作用的证据
J Natl Cancer Inst. 1988 Apr 20;80(4):241-5. doi: 10.1093/jnci/80.4.241.
5
Enhancement of the antitumor effect of flavone acetic acid by the bioreductive cytotoxic drug SR 4233 in a murine carcinoma.生物还原细胞毒性药物SR 4233增强黄酮乙酸对小鼠癌的抗肿瘤作用
Cancer Res. 1989 Oct 15;49(20):5664-70.
6
The role of immune effector cells in flavone acetic acid-induced injury to tumor cells in EMT6 spheroids.免疫效应细胞在黄酮乙酸诱导的EMT6球体肿瘤细胞损伤中的作用。
Oncol Res. 1992;4(8-9):333-9.
7
Vascular collapse after flavone acetic acid: a possible mechanism of its anti-tumour action.黄酮乙酸所致的血管塌陷:其抗肿瘤作用的一种可能机制。
Eur J Cancer Clin Oncol. 1989 Oct;25(10):1419-24. doi: 10.1016/0277-5379(89)90099-0.
8
Flavone acetic acid increases the cytotoxicity of mitomycin C when combined with hyperthermia.黄酮醋酸与热疗联合使用时可增强丝裂霉素C的细胞毒性。
Cancer Chemother Pharmacol. 1996;38(1):1-8. doi: 10.1007/s002800050439.
9
Correlation between immune and vascular activities of xanthenone acetic acid antitumor agents.呫吨酮乙酸抗肿瘤药物的免疫与血管活性之间的相关性。
Oncol Res. 1994;6(2):79-85.
10
Role of tumor necrosis factor in flavone acetic acid-induced tumor vasculature shutdown.肿瘤坏死因子在黄酮乙酸诱导的肿瘤血管关闭中的作用。
Cancer Res. 1990 Sep 1;50(17):5537-42.

引用本文的文献

1
Identification and induction of cytochrome P450s involved in the metabolism of flavone-8-acetic acid in mice.小鼠中参与黄酮 - 8 - 乙酸代谢的细胞色素P450的鉴定与诱导
Drug Metab Lett. 2011 Apr;5(2):73-84. doi: 10.2174/187231211795305221.
2
Temporal aspects of the action of ASA404 (vadimezan; DMXAA).ASA404(vadimezan;DMXAA)作用的时间方面。
Expert Opin Investig Drugs. 2010 Nov;19(11):1413-25. doi: 10.1517/13543784.2010.529128.
3
Labeling of oxidizable proteins with a photoactivatable analog of the antitumor agent DMXAA: evidence for redox signaling in its mode of action.
用一种抗肿瘤药物 DMXAA 的光活化类似物标记可氧化蛋白:其作用模式中氧化还原信号的证据。
Neoplasia. 2010 Sep;12(9):755-65. doi: 10.1593/neo.10636.
4
Antivascular effects of TZT-1027 (Soblidotin) on murine Colon26 adenocarcinoma.TZT-1027(索布力多汀)对小鼠结肠26腺癌的抗血管生成作用。
Cancer Sci. 2006 Dec;97(12):1410-6. doi: 10.1111/j.1349-7006.2006.00330.x. Epub 2006 Sep 25.
5
Relationship between tumour endothelial cell apoptosis and tumour blood flow shutdown following treatment with the antivascular agent DMXAA in mice.抗血管生成药物DMXAA治疗后小鼠肿瘤内皮细胞凋亡与肿瘤血流阻断之间的关系。
Br J Cancer. 2004 Feb 23;90(4):906-10. doi: 10.1038/sj.bjc.6601606.
6
Professor Tom Connors and the development of novel cancer therapies by the Phase I/II Clinical Trials Committee of Cancer Research UK.汤姆·康纳斯教授与英国癌症研究中心I/II期临床试验委员会新型癌症疗法的研发。
Br J Cancer. 2003 Aug 4;89(3):437-54. doi: 10.1038/sj.bjc.6601106.
7
Clinical aspects of a phase I trial of 5,6-dimethylxanthenone-4-acetic acid (DMXAA), a novel antivascular agent.新型抗血管生成药物5,6-二甲基呫吨酮-4-乙酸(DMXAA)I期试验的临床情况
Br J Cancer. 2003 Jun 16;88(12):1844-50. doi: 10.1038/sj.bjc.6600992.
8
5,6-dimethylxanthenone-4-acetic acid (DMXAA): a new biological response modifier for cancer therapy.5,6-二甲基呫吨酮-4-乙酸(DMXAA):一种用于癌症治疗的新型生物反应调节剂。
Invest New Drugs. 2002 Aug;20(3):281-95. doi: 10.1023/a:1016215015530.
9
A novel combretastatin A-4 derivative, AC7700, strongly stanches tumour blood flow and inhibits growth of tumours developing in various tissues and organs.一种新型的秋水仙素A-4衍生物AC7700能强力阻止肿瘤血流,并抑制在各种组织和器官中生长的肿瘤。
Br J Cancer. 2002 May 20;86(10):1604-14. doi: 10.1038/sj.bjc.6600296.
10
The biology of the combretastatins as tumour vascular targeting agents.作为肿瘤血管靶向剂的考布他汀生物学特性。
Int J Exp Pathol. 2002 Feb;83(1):21-38. doi: 10.1046/j.1365-2613.2002.00211.x.